Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Rhea-AI Summary

Champions Oncology (CSBR), a global preclinical and clinical research services provider specializing in oncology solutions, has announced it will release its financial and operational results for the first quarter ended July 31, 2024, on Wednesday, September 11, 2024, after market close. The company will host a conference call to discuss the results at 4:30 P.M. EDT on the same day. Investors can join the call using the provided domestic and international dial-in numbers and access code. A replay of the call will be available via phone or through the company's website within 72 hours of the call.

News Market Reaction – CSBR

-6.62%

-6.62% Session move

In the trading session that priced this news, CSBR declined 6.62%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HACKENSACK, NJ / ACCESSWIRE / September 9, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the first quarter ended July 31, 2024, on Wednesday, September 11, 2024, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 726315. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 51258, or by accessing the investors section of the company's website within 72 hours.

About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.

Media Contact:
Rachel Bunting, MS, MBA
VP, Global Marketing
Marketing@ChampionsOncology.com

SOURCE: Champions Oncology, Inc.

View the original press release on accesswire.com

FAQ

When will Champions Oncology (CSBR) report its Q1 2024 financial results?

Champions Oncology (CSBR) will report its financial and operational results for the first quarter ended July 31, 2024, on Wednesday, September 11, 2024, after market close.

What time is the Champions Oncology (CSBR) Q1 2024 earnings call scheduled for?

Champions Oncology (CSBR) will host a conference call to discuss the Q1 2024 results on Wednesday, September 11, 2024, at 4:30 P.M. EDT (1:30 P.M. PDT).

How can investors access the Champions Oncology (CSBR) Q1 2024 earnings call?

Investors can join the call by dialing 888-506-0062 (Domestic) or 973-528-0011 (International) and entering the access code 726315.

Will there be a replay available for Champions Oncology's (CSBR) Q1 2024 earnings call?

Yes, a replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 51258, or by accessing the investors section of the company's website within 72 hours.